Fundraising Fox
Scope
12 employees on LinkedIn · 2 known investors
Find your way into Scope
Sign up to see every warm intro you have to Scope
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Scope team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.
Founders & leadership
Investors · 2
SHIFT Investlisted by SHIFT InvestAmstelveen · $270K – $3.3M
How we know: SHIFT Invest's portfolio page · the VCSheet dataset · Not right? Tell us
Index VenturesreportedSan Francisco · $540K – $10.8M
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMay 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Scope do?
- Scopebio develops on-site molecular diagnostic assays for detecting crop pathogens, enabling rapid pathogen identification directly in the field. The company serves agricultural producers and offers custom assay development for emerging threats and niche crops.
- Who founded Scope?
- Scope was founded by Niek Savelkoul.
- Who are Scope's investors?
- Scope's investors include SHIFT Invest, Index Ventures.